The vulnerable groups and their silent struggles While heart attack risk increases for everyone in the cold weather, certain groups are far m ...
SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a reduced risk of COPD exacerbations in patients with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback